Publicaciones

01 de Septiembre de 2019

Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.

Pérez de Llano LA, Cosío BG, Domingo C, Urrutia I, Bobolea I, Valero A, Entrenas Costa LM, Quirce S, Barranco P, Marina Malanda N, Andrés LP, Alvarez-Gutiérrez FJ. J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2277-2283.e2. doi: 10.1016/j.jaip.2019.01.017.